STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ENTA ENANTA PHARMACEUTICALS INCORPORATED StockScouter® Report
4
StockScouter® Score
ENANTA PHARMACEUTICALS INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- Short-term relative price momentum exhibits meaningful strength. Postive
Concerns
- One or more analysts has significantly decreased quarterly earnings estimates for ENTA. Negative
- The multi-period measure of relative price change and consistency is well below average. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
B
C
D
F